- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Biomarkers in Cutaneous Melanoma
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 22, Issue 2, Pages 203-218
Publisher
Springer Nature
Online
2018-02-06
DOI
10.1007/s40291-018-0318-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
- (2017) Paola Queirolo et al. Frontiers in Immunology
- Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma
- (2016) V Armand-Labit et al. ACTA DERMATO-VENEREOLOGICA
- Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
- (2016) P. F. Ferrucci et al. ANNALS OF ONCOLOGY
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
- (2016) Benjamin Weide et al. CLINICAL CANCER RESEARCH
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Use of LDH and autoimmune side effects to predict response to ipilimumab treatment
- (2016) J Dick et al. Immunotherapy
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab-triggered Uveitis
- (2016) Stefan Diem et al. JOURNAL OF IMMUNOTHERAPY
- Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
- (2016) Sen Guo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
- (2016) Georgina V Long et al. LANCET ONCOLOGY
- Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
- (2016) Nayoung Lee et al. PATHOLOGY
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy
- (2016) Yoshio Nakamura et al. Oncotarget
- The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
- (2016) Leila Khoja et al. Cancer Medicine
- Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature
- (2016) Fernanda Costa Svedman et al. Clinical Epidemiology
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
- (2015) K Abiko et al. BRITISH JOURNAL OF CANCER
- High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
- (2015) J. Zaragoza et al. BRITISH JOURNAL OF DERMATOLOGY
- miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications
- (2015) Marco Ragusa et al. CANCER BIOLOGY & THERAPY
- Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
- (2015) P. Gerami et al. CLINICAL CANCER RESEARCH
- Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
- (2015) C. Gebhardt et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation in human melanoma: past and future
- (2015) Debina Sarkar et al. Epigenetics
- Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab
- (2015) S. Valpione et al. EUROPEAN JOURNAL OF CANCER
- MiR-21: an environmental driver of malignant melanoma?
- (2015) Bodo C Melnik Journal of Translational Medicine
- LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis
- (2015) Érica S.S. De Araújo et al. MELANOMA RESEARCH
- Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
- (2015) Cristina Fortes et al. MELANOMA RESEARCH
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines
- (2015) Ikrame Lazar et al. Pigment Cell & Melanoma Research
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
- (2015) M. R. Girotti et al. Cancer Discovery
- Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
- (2015) Jon Bjoern et al. OncoImmunology
- The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
- (2015) Mitchell S. Stark et al. EBioMedicine
- Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance
- (2014) L. Khoja et al. ANNALS OF ONCOLOGY
- Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma
- (2014) Maria Cristina Rapanotti et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
- (2014) Nathaniel H. Fleming et al. CANCER
- Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
- (2014) Ester Simeone et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- Breslow Thickness, Clark Index and Ulceration Are Associated with Sentinel Lymph Node Metastasis in Melanoma Patients: A Cohort Analysis of 612 Patients
- (2014) Coline Munsch et al. DERMATOLOGY
- Melanoma epigenetics: novel mechanisms, markers and medicines
- (2014) Jonathan J Lee et al. LABORATORY INVESTIGATION
- Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors
- (2014) Allison R Larson et al. MODERN PATHOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
- (2014) Jason Madore et al. Pigment Cell & Melanoma Research
- Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
- (2014) HAITAO LI et al. Oncology Letters
- Isolation and Molecular Characterization of Circulating Melanoma Cells
- (2014) Xi Luo et al. Cell Reports
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
- (2013) Nancy E. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
- (2013) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
- (2013) Paolo A. Ascierto et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma MicroRNA-21 Is Associated with Tumor Burden in Cutaneous Melanoma
- (2013) Gerald Saldanha et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma
- (2013) Thilo Gambichler et al. MELANOMA RESEARCH
- Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma
- (2013) Leila Khoja et al. MELANOMA RESEARCH
- miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule
- (2013) HE-FEI WANG et al. ONCOLOGY REPORTS
- Protein and non-protein biomarkers in melanoma: a critical update
- (2012) Nadine Tandler et al. AMINO ACIDS
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain
- (2012) José Antonio Avilés-Izquierdo et al. Clinical & Translational Oncology
- Sunitinib Therapy for Melanoma Patients withKITMutations
- (2012) David R. Minor et al. CLINICAL CANCER RESEARCH
- Melanoma Staging
- (2012) Adriano Piris et al. DERMATOLOGIC CLINICS
- Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice
- (2012) Srinivasan Dinesh Kumar et al. FREE RADICAL BIOLOGY AND MEDICINE
- BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
- (2012) Graham J. Mann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma
- (2012) E. Emri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells
- (2012) James B Freeman et al. Journal of Translational Medicine
- Loss of microRNA-205 expression is associated with melanoma progression
- (2012) Shujing Liu et al. LABORATORY INVESTIGATION
- In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
- (2012) Jason A Hanna et al. LABORATORY INVESTIGATION
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts
- (2012) Stefanie Meyer et al. PLoS One
- Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes
- (2012) Deyi Xiao et al. PLoS One
- Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34
- (2011) Amy E. Rose et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions
- (2011) V Grignol et al. BRITISH JOURNAL OF CANCER
- Increased serum levels of S100B are related to the severity of cardiac dysfunction, renal insufficiency and major cardiac events in patients with chronic heart failure
- (2011) Jin Ping Li et al. CLINICAL BIOCHEMISTRY
- Plasma Markers for Identifying Patients with Metastatic Melanoma
- (2011) H. M. Kluger et al. CLINICAL CANCER RESEARCH
- Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma
- (2011) M. de Vries et al. EJSO
- Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma
- (2011) Tung Nguyen et al. Epigenetics
- Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma
- (2011) Friederike Egberts et al. EUROPEAN JOURNAL OF CANCER
- Nilotinib in patients with metastatic melanoma harboring KIT gene aberration
- (2011) Jin Hyun Cho et al. INVESTIGATIONAL NEW DRUGS
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells
- (2011) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification
- (2011) Jun Guo et al. JOURNAL OF CLINICAL ONCOLOGY
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells
- (2011) Verena Kupas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients
- (2011) Luca Sigalotti et al. Journal of Translational Medicine
- Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
- (2011) Sarah J Storr et al. MODERN PATHOLOGY
- Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
- (2011) Jian Wang et al. PLoS One
- Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
- (2010) Geoffrey Y. Ku et al. CANCER
- Methods of detection of circulating melanoma cells: A comparative overview
- (2010) Andrianos Nezos et al. CANCER TREATMENT REVIEWS
- Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
- (2010) G. Jonsson et al. CLINICAL CANCER RESEARCH
- Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
- (2010) M. F. Segura et al. CLINICAL CANCER RESEARCH
- CSPG4 in Cancer: Multiple Roles
- (2010) X. Wang et al. CURRENT MOLECULAR MEDICINE
- Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma
- (2010) Caroline Conway et al. GENES CHROMOSOMES & CANCER
- Expression of the Stem Cell Markers Nestin and CD133 on Circulating Melanoma Cells
- (2010) Alberto Fusi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- S100A13 is a new angiogenic marker in human melanoma
- (2010) Daniela Massi et al. MODERN PATHOLOGY
- A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma
- (2010) S E Godshalk et al. ONCOGENE
- A role for the NG2 proteoglycan in glioma progression
- (2010) William B. Stallcup et al. Cell Adhesion & Migration
- MicroRNA-dependent regulation of cKit in cutaneous melanoma
- (2009) O. Igoucheva et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
- (2009) M. Kashani-Sabet et al. CLINICAL CANCER RESEARCH
- MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
- (2009) Maria Angelica Cortez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Processing of MIA protein during melanoma cell migration
- (2009) Jennifer Schmidt et al. INTERNATIONAL JOURNAL OF CANCER
- Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis
- (2009) Vladislava O. Melnikova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
- (2009) Bonnie E. Gould Rothberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival
- (2009) Fredrik Petersson et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma
- (2009) Matthew Petitt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma
- (2009) Maja A. Hofmann et al. MELANOMA RESEARCH
- High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma
- (2009) Yasufumi Goto et al. Pigment Cell & Melanoma Research
- A multi-marker assay to distinguish malignant melanomas from benign nevi
- (2009) M. Kashani-Sabet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
- (2009) D. Bogunovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II trial of imatinib mesylate in patients with metastatic melanoma
- (2008) K B Kim et al. BRITISH JOURNAL OF CANCER
- Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma
- (2008) T. John et al. CLINICAL CANCER RESEARCH
- Baseline Staging of Melanoma with Unknown Primary Site: The Value of Serum S100 Protein and Positron Emission Tomography
- (2008) Patrick A. Oberholzer et al. DERMATOLOGY
- MicroRNA-221 and -222 pathway controls melanoma progression
- (2008) Federica Felicetti et al. Expert Review of Anticancer Therapy
- The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis
- (2008) Simone Mocellin et al. INTERNATIONAL JOURNAL OF CANCER
- Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
- (2008) Tobias Zellweger et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694
- (2008) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis
- (2008) Katie Doeden et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy
- (2007) R.A. Pearl et al. Journal of Plastic Reconstructive and Aesthetic Surgery
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started